Your #AACR26 Monday schedule at a glance!

Start the morning with Yujin Hoshida, M.D., Ph.D., on biomarker-guided precision prevention of HCC, followed by Ralph DeBerardinis, M.D., Ph.D., on how NUDT5 regulates purine nucleotide synthesis and chemotherapy response.

@HoshidaYujin